RITA GELSOMINI GRUBER: Open Payments
NPI 1770659831 · PORTSMOUTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 85 payments from 10 companies in 2025. Trend: 2023 $194 · 2024 $856 · 2025 $1,220
Food & beverage: $1,220
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $286 |
| Axsome Therapeutics, Inc. | 15 | $184 |
| Lundbeck LLC | 17 | $170 |
| ABBVIE INC. | 9 | $162 |
| Janssen Pharmaceuticals, Inc | 9 | $146 |
| Supernus Pharmaceuticals, Inc. | 7 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Alkermes, Inc. | 1 | $14 |
Products named: Auvelity, REXULTI, VRAYLAR, AUSTEDO XR, UZEDY, INVEGA SUSTENNA, Qelbree, TRINTELLIX.
Industry payments across NH — which companies pay providers there.
